TheProfitWatch

APGE - Apogee Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
63.23 3.35 (5.29%) 0.14 (0.22%) 0.06 (0.08%) 0.35 (0.53%) --- 3.35 (5.29%) --- ---

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.13
Diluted EPS:
-1.13
Basic P/E:
-58.9159
Diluted P/E:
-58.9159
RSI(14) 1m:
65.03
VWAP:
66.57
RVol:

Events

Period Kind Movement Occurred At

Related News